Equities research analysts expect that Novartis will post 8.42 EPS for the current fiscal year. Novartis AG engages in the research, development, manufacture, and marketing of healthcare products in ...

At Novartis India, the focus on gender equality and the promotion of women in leadership roles is not just a corporate initiative—it's a commitment ingrained in the organisation's culture. Speaking to ...